Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Lung cancer illustration

Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

T-cells illustration

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

CEPI Funds New Broad Coronavirus Vaccine

Exosome illustration

An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine

Semiconductor Tech Drug Discovery Company Underway

Neurons on electrodes

A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway

NIH Funding Nanoparticle Gene Therapy for Opioid Disorder

DNA puzzle

National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder. . . . → Read More: NIH Funding Nanoparticle Gene Therapy for Opioid Disorder

New Industry, Academic Studies Arrive at Space Station

International Space Station

Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions. . . . → Read More: New Industry, Academic Studies Arrive at Space Station

Exosomes Shown to Block Broad Covid-19 Variant Range

Exosome illustration

Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range

Biotech Partners on Gene Editing Tech in $1.35B Deal

Gene therapy graphic

A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal

Trial Set for Covid-19 Nasal Spray Vaccine

Nasal spray

A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands. . . . → Read More: Trial Set for Covid-19 Nasal Spray Vaccine

Joint Venture to Develop Stable RNA Covid-19 Vaccine

Shark

A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine